Volume 54, Issue 3 pp. 309-317
Original Study

A novel quantitative method for evaluating diffuse in-stent narrowing at follow-up angiography

Yasuhiro Ishii MD

Yasuhiro Ishii MD

Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands

Heart Core B.V., Leiden, The Netherlands

Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands

Search for more papers by this author
Anton W.M. van Weert PhD

Anton W.M. van Weert PhD

Heart Core B.V., Leiden, The Netherlands

Search for more papers by this author
Ellen Hekking

Ellen Hekking

Heart Core B.V., Leiden, The Netherlands

Search for more papers by this author
Karen de Marie

Karen de Marie

Heart Core B.V., Leiden, The Netherlands

Search for more papers by this author
Jeroen ter Horst

Jeroen ter Horst

Heart Core B.V., Leiden, The Netherlands

Search for more papers by this author
Pranobe V. Oemrawsingh MD

Pranobe V. Oemrawsingh MD

Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands

Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands

Search for more papers by this author
Johan H.C. Reiber PhD

Corresponding Author

Johan H.C. Reiber PhD

Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands

Heart Core B.V., Leiden, The Netherlands

Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands

In accordance with the policy of the Journal, the designated author discloses a financial or other interest in the subject discussed in this article.

Department of Radiology, C2-S, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The NetherlandsSearch for more papers by this author
First published: 24 October 2001
Citations: 2

Abstract

A new quantitative parameter, diffuse index (DI), was proposed to evaluate objectively whether in-stent restenosis is diffuse or focal in nature. A total of 343 patients (346 lesions) with Wiktor-GX, AVE MS-II, or JOMED stents were evaluated at follow-up angiography. According to the QCA-CMS definition, lesion length is derived from the 100% reference diameter function (RDF). By moving the RDF downward, the lesion length, LL(x), at each percentage x of the RDF can be calculated. We have defined the DI by the ratio of this calculated length LL(x) and the total stent length, SL, in other words, DI = [LL(x)/SL]. The percentage plaque area (% PA) was calculated by dividing the plaque area by the sum of the plaque area and luminal area within the stent. An excellent correlation was found between the DI at 88% RDF and the % PA in all three stents (r > 0.88). The individual correlation curves were nearly identical, independent of the type of stent. Furthermore, based on the overall data, the combination of a DI > 0.8 and % PA > 30% correlated with a high incidence of subsequent major adverse cardiac events (13/25 = 52%). From these data, it can be concluded that the diffuse index is a new objective quantitative parameter to describe whether in-stent restenosis is of focal or diffuse nature. Cathet Cardiovasc Intervent 2001;54:309–317. © 2001 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.